Axillary recurrence is low in patients with breast cancer who do not undergo completion axillary lymph node dissection for micrometastases in sentinel lymph nodes

American Surgeon

Volumn 76, Issue 10, 2010, Pages 1088-1091

  Rayhanabad, Jessica ^a   Yegiyants, Sara ^a   Putchakayala, Krishna ^a   Haigh, Philip ^a   Romero, Lina ^a   Difronzo, L Andrew ^a  

^a KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER INCIDENCE; CANCER RECURRENCE; COMPLETION AXILLARY LYMPH NODE DISSECTION; CONTROLLED STUDY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MICROMETASTASIS; NOMOGRAM; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE; TUMOR VOLUME;

ADULT; AGED; AXILLA; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES;

EID: 78651366627     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Greene FL, Page DL, Fleming ID. AJCC Cancer Staging Manual, 6th ed. New York: Springer; 2002.
2. Lyman F, Giuliano AE, Somerfield M, et al. American Society of Clinical Oncology Guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 2005;23:7703-20.
3. Wasif N, Ye X, Giuliano A. Survey of ASCO members on management of sentinel node micrometastases in breast cancer: variation in treatment recommendations according to specialty. Ann Surg Oncol 2009;16:2442-9.
4. Cox CE, Kiluk JV, Riker AI, et al. Significance of sentinel lymph node micrometastases in human breast cancer. J Am Coll Surg 2008;206:261-8.
5. De Boer M, van Deurzen CH, van Dijck JA, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 2009;361:653-63.
6. Langer I, Fuller U, Viehl CT, et al. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study. Ann Surg Oncol 2009;16:3366-74.
7. Van Zee KJ, Manasseh DM, Bevilacqua JL, et al. A nomo-gram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003;10:1140-51.
8. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel lymph nodes. Arch Surg 2003;138:52-6.
9. Alran S, De Rycke Y, Rourchotte V, et al. Validation and limitations of use of a breast cancer nomogram predicting the likelihood of non-sentinel lymph node involvement in sentinel node positive breast cancer patients. Ann Surg Oncol 2007;14:2195-201.
10. Fisher B, Brown A, Mamounas E, et al. Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from the National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 1997;15:2483-93. (Pubitemid 27289876)